Jane Ussher: Challenging Medicalization of Postpartum Depression
Jane Ussher, Professor of Women’s Health Psychology at Western Sydney University, shared a post on LinkedIn about a paper by Lisa Cosgrove et al. published in Women’s Reproductive Health:
“Using zuranolone as a case study, this paper shows how industry and academia reinforce the medicalisation of women’s distress, overstating benefits while downplaying harms, and deflecting attention from the social and economic drivers of postpartum suffering.”
Title: Take Back the Narrative: What Women and Healthcare Providers Need to Know About the “First-Ever” Pill for Postpartum Depression
Authors: Lisa Cosgrove, Fiona Wu, Maeve Silman, Edie Gobel, Emilija Jankov, Lena Matković, Marija Milovanović, Dinah Akua Odea Ansah
Read the full article.

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Mar 4, 2026, 09:30Nikhil Patil: Contraceptive Use Among Married Women of Reproductive Age
-
Mar 4, 2026, 06:17Human Embryo Testing and Evidence-Based Validation Examined in New Publication – Fertility and Sterility
-
Mar 3, 2026, 00:23Final Call for Review of Updated ESHRE IVF Laboratory Recommendations – ESHRE
-
Mar 3, 2026, 00:15Abstract Submissions Are Now Open for ASM 2026! – BSGI
-
Mar 2, 2026, 14:06Ever Wondered How Ovulation Works? Let’s Break It Down! – Fertility Plus
-
Mar 2, 2026, 13:48Join RBMO Webinar on Global Declining Fertility Rates – RBMO
-
Mar 2, 2026, 13:39Governance of Polygenic Embryo Screening – Fertility and Sterility
-
Mar 2, 2026, 13:26AJOG MFM February 2026 Podcast Episode Is Out!
-
Mar 2, 2026, 13:21Yousef Zakharia Leads Clinical Research Aimed at Genitourinary Cancers – Mayo Clinic
